Advertisement

Gastric Dysplasia

  • P. Sipponen
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 81)

Abstract

The correct diagnosis of dysplasia provides an opportunity for the identification and treatment of cancer in an early phase. It also provides the potential to recognise subjects who have a particularly high risk of cancer. Proper identification and management of dysplastic lesions have led to success in population-wide prevention of some common cancers, especially cancer of cervix and, to a lesser extent, cancer of colon and rectum. Less success has been achieved in the diagnosis and treatment of gastric dysplasia.

Keywords

Gastric Cancer Gastric Mucosa Gastric Carcinoma Early Gastric Cancer Intestinal Metaplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersson AP, Lauritsen KB, West F, Johansen A (1987) Dysplasia in gastric mucosa: prognostic significance. Acta Chir Scand 153:29–31PubMedGoogle Scholar
  2. Aste H, Sciallero S, Pugliese V, Gennaro M (1986) The clinical significance of gastric epithelial dysplasia. Endoscopy 18:174–176PubMedCrossRefGoogle Scholar
  3. Barlogie B (1984) Abnormal cellular DNA content as a marker of neoplasia. Eur J Cancer Clin Oncol 20:1123–1125PubMedCrossRefGoogle Scholar
  4. Blaszczyk-Thurin M, Thurin J, Hindsgaul O, Karlsson KA, Steplewski Z, Koprowski H (1987) Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy. J Biol Chem 262:372–279PubMedGoogle Scholar
  5. Borch K, Renvall H, Lundin C, Wahren B (1987) Evaluation of gastric carcinoembryonic antigen analysis as an aid during screening for gastric neoplasia in atrophic gastritis. Gut 28:26–32PubMedCrossRefGoogle Scholar
  6. Camilleri JP, Potet F, Amat C, Molas G (1984) Gastric mucosal dysplasia: preliminary results of a prospective study of patients followed for periods of up to six years. In: Ming S-C (ed) Precursors of gastric cancer. Praeger, New York, pp 83–92Google Scholar
  7. Ciclitira PJ, Macartney JC, Evan G (1987) Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol 151:293–296PubMedCrossRefGoogle Scholar
  8. Coon JS, Weinstein RS (1986) Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinomas. Hum Pathol 17:1089–1106PubMedCrossRefGoogle Scholar
  9. Correa P (1985) Mechanisms of gastric carcinogenesis. Int Congr Ser 685:109–115Google Scholar
  10. Cuello C, Correa P, Zarama G, Lopez J, Murray J, Gordillo G (1979) Histopathology of gastric dysplasia: correlations with gastric juice histochemistry. Am J Surg Pathol 3:491–500PubMedCrossRefGoogle Scholar
  11. Czerniak B, Herz F, Koss LG, Schlom J (1987) Ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas. Cancer 60:2432–2436PubMedCrossRefGoogle Scholar
  12. Denk H, (1979) Blood group antigens and carcinoembryonic antigen in gastric cancer. In: Pfeiffer CJ (ed) Gastric cancer. Gerhard Witzstrock, New York, pp 191–208Google Scholar
  13. Ectors N, Dixon MF (1986) The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 10:1271–1277PubMedCrossRefGoogle Scholar
  14. Feizi T(1982) Blood group antigens and gastric cancer. Med Biol 60:7–11PubMedGoogle Scholar
  15. Ferti-Passantonopoulou AD, Panani AD, Vlachos JD, Paptis SA (1987) Common cytogenetic findings in gastric cancer. Cancer Genet Cytogenet 24:63–73PubMedCrossRefGoogle Scholar
  16. Filipe MI, Jass JR (1986) Intestinal metaplasia subtypes and cancer risk. In: Filipe MI, Jass JR (eds) Gastric cancer. Churchill Livingstone, Edinburgh, pp 87–115Google Scholar
  17. Filipe MI, Potet F, Bogomoletz WV et al. (1985) Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 26:1319–1326PubMedCrossRefGoogle Scholar
  18. Fischer J, Klein PJ, Vierbuchen M, Skutta B, Uhlenbruck G, Fischer R (1984) Characterization of glycoconjugates of human gastrointestinal mucosa by lectins. I. Histochemical distribution of lectin binding sites in normal alimentary tract as well as in benign and malignant gastric neoplasms. J Histochem Cytochem 32:681–689PubMedCrossRefGoogle Scholar
  19. Fujita S (1978) Biology of early gastric carcinoma. Path Res Pract 163:297–309PubMedCrossRefGoogle Scholar
  20. Fujita S, Hattori T (1977) Cell proliferation, and migration in the gastric mucosa: a study on the background of carcinogenesis. In: Farber E (ed) Pathophysiology of carcinogenesis in digestive organs. University of Tokyo Press, Tokyo/University Park Press, Baltimore, pp 21–36Google Scholar
  21. Fukushige S, Matsubara K, Yoshida M et al. (1986) Localization of a novel v-erb-related gene, c-erb-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol 6:955–958PubMedGoogle Scholar
  22. Graem N, Fischer AB, Beck H (1984) Dysplasia and carcinoma in Billroth II resected stomach 27–35 years postoperatively. Acta Pathol Microbiol Immunol Scand [A] 92:185–188Google Scholar
  23. Grundmann E (1975) Histologic types and possible initial stages in early gastric carcinoma. Beitr Pathol 154:256–280PubMedGoogle Scholar
  24. Häkkinen IP, Heinonen R, Isberg U, Järvi OH (1984) Canine gastric glycoprotein antigens in early carcinogenesis. Cancer 53:928–934PubMedCrossRefGoogle Scholar
  25. Hattori T (1986) Development of adenocarcinomas in the stomach. Cancer 57:1528–1534PubMedCrossRefGoogle Scholar
  26. Heilmann KL (1978) Gastritis-Intestinale Metaplasie-Karzinom. Thieme, StuttgartGoogle Scholar
  27. Hermanek P (1979) Gastric polyps and gastric carcinoma. In: Herfarth C, Schlag P (eds) Gastrin cancer. Springer, Berlin Heidelberg New York, pp 147–148CrossRefGoogle Scholar
  28. Higgins PJ, Correa P, Cuello C, Lipkin M (1984) Fetal antigens in the precursor stages of gastric cancer. Oncology 41:73–76PubMedCrossRefGoogle Scholar
  29. Jarvis LR, Whitehead R (1985) Morphometric analysis of gastric dysplasia. Pathol 147:133–138CrossRefGoogle Scholar
  30. Jass JR (1983) A classification of gastric dysplasia. Histopathology 7:181–193PubMedCrossRefGoogle Scholar
  31. Jass JR, Strudley I, Falady J (1984) Histochemistry of epithelial metaplasia and dysplasia in human stomach and colorectum. Scand J Gastroenterol 104:109–130Google Scholar
  32. Johansen AB (1981) Early gastric cancer. A contribution to the pathology and to gastric cancer histogenesis. Bispebjerg Hospital, CopenhagenGoogle Scholar
  33. Kapadia A, Feizi T, Jewell D, Keeling J, Slavin G (1981) Immunocytochemical studies of blood group A, H, I and i antigens in gastric mucosa of infants with normal gastric histology and of patients with gastric carcinoma and chronic peptic ulceration. J Clin Pathol 34:320–337PubMedCrossRefGoogle Scholar
  34. Kawai K (1974) Doubtful cases and precancerous lesions. In: Grundmann E, Gruntze H, Witte S (eds) Early gastric cancer. Springer, Berlin Heidelberg New York, pp 177–179CrossRefGoogle Scholar
  35. Korenaga D, Mori M, Okamura T, Sugimachi K, Enjoji M (1986) DNA ploidy in clinical malignant gastric lesions less than 5 mm in diameter. Cancer 58:2542–2545PubMedCrossRefGoogle Scholar
  36. Kralovanszky J, Szentirmay Z, Besznyak I, Eckhardt S (1984) Placental type alkaline phosphatase in possibly premalignant alterations of human gastric mucosa. Oncology 41:189–194PubMedCrossRefGoogle Scholar
  37. Lei DN, Yu JY (1984) Types of intestinal metaplasia in relation to the histogenesis of gastric carcinoma. Arch Pathol Lab Med 108:220–224PubMedGoogle Scholar
  38. Lipkin M, Correa P, Mikol VB et al. (1985) Proliferative and antigenic modifications in human epithelial cells in chronic atrophic gastritis J Natl Cancer Inst 75:613–619PubMedGoogle Scholar
  39. Macartney JC, Camplejohn RS (1986) DNA flow cytometry of histological material from dysplastic lesions of human gastric mucosa. J Pathol 150:113–118PubMedCrossRefGoogle Scholar
  40. Meister H, Holubarsch CH, Haferkamp O, Schlag P, Herfarth C (1979) Gastritis, intestinal metaplasia and dysplasia versus benign ulcer in stomach and duodenum and gastric carcinoma. A histotopographic study. Path Res Pract 164:259–269PubMedCrossRefGoogle Scholar
  41. Ming S-C (1979) Dysplasia of gastric epithelium. Front Gastrointest Res 4:164–172PubMedGoogle Scholar
  42. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen A (1980) Precancerous conditions and epithelial dysplasia in stomach. J Clin Pathol 33:711–721PubMedCrossRefGoogle Scholar
  43. Mortensen NJ, Thomas WE, Jones SM, Savage A (1984) Endoscopic screening for premalignant changes 25 years after gastrectomy: results of a five-year prospective study. Br J Surg 71:363–367PubMedCrossRefGoogle Scholar
  44. Nagayo T, (1971) Histological diagnosis of biopsied gastric mucosae with special reference to that of borderline lesions. Gann Monogr 11:245–256Google Scholar
  45. Nagayo T (1986) Histopathology of gastric dysplasia. ïn:Filipe MI, Jass JR (eds) Gastric cancer. Churchill Livingstone, Edinburgh, pp 116–131Google Scholar
  46. Nakatani H, Tahara E, Yoshida T et al. (1986) Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Jpn J Cancer Res 77:849–853PubMedGoogle Scholar
  47. Nardelli J, Bara J, Rosa B, Burtin P (1983) Intestinal metaplasia and carcinomas of the human stomach. An immunohistological study. J Histochem Cytochem 31:366–375PubMedCrossRefGoogle Scholar
  48. Noguchi M, Hirohashi S, Shimosato Y et al. (1986) Histologic demonstration of antigens reactive with anti-P21 Ras monoclonal antibody (Rap-5) in human stomach cancers. J Natl Cancer Inst 77:379–385PubMedGoogle Scholar
  49. Ochuchi N, Thor A, Nose M, Fukita J, Kyogoku M, Schlom J (1986) Tumor-associated glycoprotein (TAG-72) detected in adenocarcinomas and benign of the stomach. Int J Cancer 38:643–650CrossRefGoogle Scholar
  50. Ochuchi N, Hand PH, Merlo G et al. (1987) Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Cancer Res 47:1413–1420Google Scholar
  51. Oehlert W (1984) Preneoplastic lesions of the stomach. In: Ming S-C (ed) Precursors of gastric cancer. Praeger, New York, pp 73–82Google Scholar
  52. Oehlert W, Keller P, Henke M, Strauch M (1975) Dysplasien der Magenschleimhaut. Dtsch Med Wochenschr 100:1950–1956PubMedCrossRefGoogle Scholar
  53. Offerhaus GJ, Huibregtse K, de Baer J, Verhoeven T, van Olffen GH, van de Stadt J, Tytgat GN (1984) The operated stomach: a premalignant condition? A prospective follow-up study. Scand J Gastronenterol 19:521–524Google Scholar
  54. Offerhaus GJ, van de Stadt J, Samson G, Tytgat GN (1985) Cell proliferation kinetics in the gastric remnant. Eur J Cancer Clin Oncol 21:73–79PubMedCrossRefGoogle Scholar
  55. O’Hara BM, Oskarsson M, Tainsky MA, Blair DG (1986) Mechanisms of activation of human Ras genes cloned from a gastric adenocarcinoma and a pancreatic carcinoma cell line. Cancer Res 46:4695–4700PubMedGoogle Scholar
  56. Pagnini CA, Farini R, Cardin F, Di Mario F, Rugge M, Naccarato R (1983) Gastric epithelial dysplasia and sulphomucin-type intestinal metaplasia. Tumori 69:355–357PubMedGoogle Scholar
  57. Ramesar KCRB, Sanders DSA, Hopwood D (1987) Limited value of type III intestinal metaplasia in predicting risk of gastric carcinoma. J Clin Pathol 40:1287–1290PubMedCrossRefGoogle Scholar
  58. Riemann JF, Schmidt H, Hermanek P (1983) On the ultrastructure of the gastric “borderline lesion”. J Cancer Res Clin Oncol 105:285–291PubMedCrossRefGoogle Scholar
  59. Rothery GA, Day DW (1985) Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa. J Clin Pathol 38:613–621PubMedCrossRefGoogle Scholar
  60. Rubio CA, Kato Y, Sugano H (1984) The intramucosal cysts of the stomach. VI. Their quanti ative and qualitative characteristics in focal (elevated) neoplastic lesions. Path Res Pract 179:105–109PubMedCrossRefGoogle Scholar
  61. Sakai K, Mori S, Mori T, Kobori O, Morioka Y, Kano K (1985) Anomalous expression of HLA antigens in gastric cancer. Jpn J Cancer Res 30:162Google Scholar
  62. Sakai K, Mori S, Kawamoto T etal. (1986) Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst 77:1047–1052PubMedGoogle Scholar
  63. Schade ROK (1974) The borderline between benign and malignant lesions in the stomach. In: Grundmann E, Gruntze H, Witte S (eds) Early gastric cancer. Springer, Berlin, Heidelberg, New York, pp 45–53CrossRefGoogle Scholar
  64. Seki T, Fujii G, Mori S, Tamaoki N, Shibuya M (1985) Amplification of c-yes-1 proto-oncogene in a primary human gastric cancer. Jpn J Cancer Res 76:907–910PubMedGoogle Scholar
  65. Serck-Hanssen A, Osnes M, Myren J (1984) Epithelial dysplasia in the stomach: the size of the problem and some preliminary results of a follow-up study. In: Ming S-C (ed) Precursors of gastric cancer. Praeger, New York, pp 53–71Google Scholar
  66. Sipponen P, Seppälä K, Varis K, Hjelt L, Siurala M (1980) Intestinal metaplasia with colonic type sulphomucins in the gastric mucosa. Its association with gastric carcinoma. Acta Pathol Microbiol Scand [A]88:217–221Google Scholar
  67. Sprenger E, Witte S (1980) The diagnostic significance of flow cytometric nuclear DNA measurement in gastroscopic diagnosis of the stomach. Path Res Pract 169:269–275PubMedCrossRefGoogle Scholar
  68. Stockbrugger RW, Menon GG, Beilby JO, Mason RR, Cotton PB (1983) Gastroscopic screening in 80 patients with pernicious anaemia. Gut 24:1141–1147PubMedCrossRefGoogle Scholar
  69. Szentirmay Z, Csuka O, Sugar J (1986) DNA and enzyme histochemistry of dysplasia and gastric cancer. In: Filipe MI; Jass JR (eds) Gastric cancer. Churchill Livingstone, Edinburgh, pp 68–86Google Scholar
  70. Teglbjaerg PS, Nielsen HO (1978) “Small intestinal type” and “colonic type” intestinal metaplasia of the human stomach, and their relationship to the histogenetic types of gastric adenocarcinoma. Acta Pathol Microbiol Scand [A]86:351–355Google Scholar
  71. Turani H, Lurie B, Chaimoff C, Kessler E (1986) The diagnostic significance of sulfated acid mucin content in gastric intestinal metaplasia with early gastric cancer. Am J Gastroenterol 81:343–345PubMedGoogle Scholar
  72. Westerveld BD, Pals G, Defize J et al. (1986) Pepsinogen A polymorphism in gastric mucosa and urine, with special reference to patients with gastric cancer. Clin Genet 30:202–212PubMedCrossRefGoogle Scholar
  73. Zhang Y (1984) Epithelial dysplasia of the stomach and its relationship with gastric cancer. In: Ming S-C (ed) Precursors of gastric cancer. Praeger, New York, pp 41–52Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • P. Sipponen

There are no affiliations available

Personalised recommendations